XML 20 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statement of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2021   134.8      
Beginning balance at Dec. 31, 2021 $ 705.7 $ 1.3 $ 3,369.5 $ (2,570.7) $ (94.4)
Shareholders' Equity (Deficit) [Roll Forward]          
Net income 250.2     250.2  
Equity-based compensation expense 21.1   21.1    
Stock option exercises (in shares)   0.3      
Stock option exercises 8.3 $ 0.1 8.2    
Coworker Stock Purchase Plan 4.4   4.4    
Dividends paid (67.5)   0.5 (68.0)  
Incentive compensation plan stock withheld for taxes (20.4)     (20.4)  
Unrealized gain from hedge accounting 0.4       0.4
Reclassification of cash flow hedge to net income 0.8       0.8
Foreign currency translation and other (9.9)       (9.9)
Ending balance (in shares) at Mar. 31, 2022   135.1      
Ending balance at Mar. 31, 2022 893.1 $ 1.4 3,403.7 (2,408.9) (103.1)
Beginning balance (in shares) at Dec. 31, 2022   135.5      
Beginning balance at Dec. 31, 2022 1,603.3 $ 1.4 3,518.1 (1,763.8) (152.4)
Shareholders' Equity (Deficit) [Roll Forward]          
Net income 230.1     230.1  
Equity-based compensation expense 20.8   20.8    
Stock option exercises (in shares)   0.5      
Stock option exercises 12.8   12.8    
Coworker Stock Purchase Plan 5.0   5.0    
Repurchases of common stock (in shares)   (1.0)      
Repurchases of common stock (200.0)     (200.0)  
Dividends paid (79.9)   0.6 (80.5)  
Incentive compensation plan stock withheld for taxes (31.6)     (31.6)  
Unrealized gain from hedge accounting 0.0        
Reclassification of cash flow hedge to net income 0.0        
Foreign currency translation and other 8.4     (1.2) 9.6
Ending balance (in shares) at Mar. 31, 2023   135.0      
Ending balance at Mar. 31, 2023 $ 1,568.9 $ 1.4 $ 3,557.3 $ (1,847.0) $ (142.8)